Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,607 | 75,212 | 188,170 | 307,405 | 68,114 |
| Marketable Securities | 23,002 | 18,004 | 57,061 | 25,321 | 145,772 |
| Other current assets | 0 | 0 | 0 | 647 | 0 |
| TOTAL | $58,386 | $101,660 | $254,697 | $344,568 | $224,941 |
| Non-Current Assets | |||||
| PPE Net | 219 | 23,424 | 28,240 | 18,970 | 4,010 |
| Investments And Advances | 0 | 0 | 0 | 519 | 582 |
| Other Non-Current Assets | 748 | 571 | 5,884 | 5,087 | 1,177 |
| TOTAL | $967 | $23,995 | $34,124 | $24,576 | $5,769 |
| Total Assets | $59,353 | $125,655 | $288,821 | $369,144 | $230,710 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 442 | 416 | N/A | N/A |
| Accounts payable and accrued liabilities | 459 | 2,413 | 9,628 | 12,614 | 13,042 |
| Accrued Expenses | 5,136 | 21,008 | 24,604 | 17,768 | 9,164 |
| TOTAL | $11,595 | $23,863 | $70,056 | $54,877 | $22,206 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 19,149 | 19,591 | N/A | N/A |
| Deferred Revenues | N/A | N/A | 35,408 | 24,495 | N/A |
| Other Non-Current Liabilities | 28 | 6 | 454 | 15,910 | 6,771 |
| TOTAL | $28 | $19,338 | $120,208 | $104,795 | $7,229 |
| Total Liabilities | $11,623 | $43,201 | $190,264 | $159,672 | $29,435 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 51,962 | 50,426 | 49,340 | 48,920 | 48,281 |
| Common Shares | 51 | 50 | 49 | 49 | 48 |
| Retained earnings | -667,519 | -625,689 | -595,588 | -467,212 | -449,796 |
| Other shareholders' equity | -15 | -3 | 45 | 114 | 156 |
| TOTAL | $47,730 | $82,454 | $98,557 | $209,472 | $201,275 |
| Total Liabilities And Equity | $59,353 | $125,655 | $288,821 | $369,144 | $230,710 |